Expertise

Alzheimer's Disease

Alzheimer's disease and mild cognitive impairment represent significant challenges for individuals and families. The NeuroMist-QPAN TPS Programme offers advanced neuromodulation treatment targeting the deeper brain structures affected by neurodegenerative processes.

Autism Anxiety ADHD Depression Addiction Epilepsy Alzheimer's Parkinson's OCD Learning Difficulties

Understanding Alzheimer's Disease

Alzheimer's disease is a progressive neurodegenerative condition that affects memory, thinking, and behaviour. It is the most common cause of dementia, affecting millions of people worldwide. While there is currently no cure, emerging treatments including Transcranial Pulse Stimulation (TPS) offer hope for slowing progression and improving quality of life.

Mild cognitive impairment (MCI) represents an early stage where cognitive changes are noticeable but don't significantly interfere with daily functioning. Early intervention at this stage may be particularly beneficial.

Have Questions?

Ask about this treatment or discuss your options with Dr Aydin.

Get in Touch

020 8243 8590 - 020 8144 9884

Why TPS for Alzheimer's Disease

TPS (Transcranial Pulse Stimulation) is particularly suited to neurodegenerative conditions because it can reach deeper brain structures鈥攈ippocampus, thalamus, and other subcortical regions鈥攖hat are affected in Alzheimer's disease but are difficult to target with other non-invasive neuromodulation techniques.

Subcortical Access

Where rTMS excels at cortical modulation, TPS delivers focused acoustic pulses capable of reaching deeper brain structures. This opens therapeutic pathways for neurodegenerative conditions where cortical intervention alone proves insufficient.

Neuronavigation-Guided Precision

TPS integrates with advanced neuronavigation systems, enabling millimetre-accurate targeting of specific brain regions identified through QEEG analysis. This ensures every pulse reaches its intended destination with reproducible accuracy.

Ready to Start?

Take the first step towards understanding and treatment.

Get in Touch

020 8243 8590 - 020 8144 9884

Our Treatment Approach

Our TPS programme for Alzheimer's disease begins with comprehensive assessment including QEEG brain mapping to identify specific areas of dysfunction. Treatment protocols are personalised based on individual neurophysiological profiles.

The treatment process involves:

  • Initial QEEG brain mapping to assess brain function
  • Development of personalised TPS protocol targeting affected regions
  • Regular treatment sessions using neuronavigation guidance
  • Ongoing monitoring and protocol adjustment based on response
  • Support for families and caregivers

Need Support?

Our team is here to help you explore your options.

Get in Touch

020 8243 8590 - 020 8144 9884

What to Expect

TPS treatment for Alzheimer's disease is a non-invasive procedure. Sessions typically last varies and are well-tolerated. The number of sessions and treatment duration will be discussed during your consultation based on the stage of the condition and individual response.

While TPS cannot reverse Alzheimer's disease, research suggests it may help slow progression and improve certain cognitive functions. Outcomes vary between individuals, and we'll discuss realistic expectations during your consultation.

Book a Consultation

Discuss your concerns with Dr Aydin and explore your options in a confidential consultation.

Get in Touch

020 8243 8590 - 020 8144 9884

Explore TPS for Alzheimer's

If you or a loved one is dealing with Alzheimer's disease or mild cognitive impairment, TPS treatment may offer a new therapeutic pathway. Contact us to discuss whether TPS could be appropriate.

Call Now Book Now